BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36151596)

  • 21. Precancerous lesions of cervix among women infected with HIV in Referral Hospitals of Amhara Region, Northwest Ethiopia: a cross sectional study.
    Kassa LS; Dile WM; Zenebe GK; Berta AM
    Afr Health Sci; 2019 Mar; 19(1):1695-1704. PubMed ID: 31149000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Cervical Cancer Screening Programs in Côte d'Ivoire, Guyana, and Tanzania: Effect of HIV Status.
    Anderson J; Wysong M; Estep D; Besana G; Kibwana S; Varallo J; Sun K; Lu E
    PLoS One; 2015; 10(9):e0139242. PubMed ID: 26405784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review of the effects of visual inspection with acetic acid, cryotherapy, and loop electrosurgical excision procedures for cervical dysplasia in HIV-infected women in low- and middle-income countries.
    Forhan SE; Godfrey CC; Watts DH; Langley CL
    J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3():S350-6. PubMed ID: 25768874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unraveling cervical cancer screening dilemmas: histopathological insights from VIA and LEEP at bugando medical centre, Mwanza.
    Kaizilege GK; Ndaboine E; Chuma C; Mujuni F; Kiritta R; Matovelo D; Ottoman O; Elias E; Masalu N; Kidenya BR; Mazigo HD
    BMC Cancer; 2024 Jan; 24(1):66. PubMed ID: 38216912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation and feasibility of an adapted two-stage visual inspection with acetic acid/cryotherapy-based cervical cancer screening programme for HIV-infected women in Addis Ababa, Ethiopia.
    Price JT; Asgary R
    Eur J Cancer Care (Engl); 2016 May; 25(3):526-7. PubMed ID: 27121898
    [No Abstract]   [Full Text] [Related]  

  • 26. Screen-and-treat approach to cervical cancer prevention using visual inspection with acetic acid and cryotherapy: experiences, perceptions, and beliefs from demonstration projects in Peru, Uganda, and Vietnam.
    Paul P; Winkler JL; Bartolini RM; Penny ME; Huong TT; Nga le T; Kumakech E; Mugisha E; Jeronimo J
    Oncologist; 2013; 18 Suppl():6-12. PubMed ID: 24334477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
    Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
    PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the scale-up of cervical cancer screening in Abidjan stratified by HIV status.
    Boni S; Tchounga B; Comoe K; Guie P; Adié M; Horo A; Messou E; Ekouévi DK; Dabis F; Adoubi I; Jaquet A
    Int J Gynaecol Obstet; 2019 Nov; 147(2):246-251. PubMed ID: 31482577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
    Omenge Orang'o E; Liu T; Christoffersen-Deb A; Itsura P; Oguda J; Washington S; Chumba D; Pisharodi L; Cu-Uvin S; Rositch AF
    AIDS; 2017 Jan; 31(2):233-240. PubMed ID: 28002084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of visual Inspection With Acetic Acid for Cervical Cancer Screening as Compared to Human papillomavirus Deoxyribonucleic acid Testing Among Women With HIV in Ethiopia: A Comparative Cross-sectional Study.
    Bogale AL; Teklehaymanot T; Kassie GM; Medhin G; Ali JH; Belay NB
    Cancer Control; 2022; 29():10732748221114980. PubMed ID: 35829643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation and scale-up of a single-visit, screen-and-treat approach with thermal ablation for sustainable cervical cancer prevention services: a protocol for a stepped-wedge cluster randomized trial in Kenya.
    Shin MB; Oluoch LM; Barnabas RV; Baynes C; Fridah H; Heitner J; Kerubo MB; Ngure K; Pinder LF; Thomas KK; Mugo NR; Gimbel S
    Implement Sci; 2023 Jun; 18(1):26. PubMed ID: 37365575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of precancerous cervical lesions in women attending Mezam Polyclinic Bamenda, Cameroon.
    Nkfusai NC; Mubah TM; Yankam BM; Tambe TA; Cumber SN
    Pan Afr Med J; 2019; 32():174. PubMed ID: 31303943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thermo-coagulation versus cryotherapy for treatment of cervical precancers: A prospective analytical study in a low-resource African setting.
    Chigbu CO; Onwudiwe EN; Onyebuchi AK
    J Obstet Gynaecol Res; 2020 Jan; 46(1):147-152. PubMed ID: 31595603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of precancerous lesions and other cervical abnormalities among internally displaced women in Benue State Nigeria.
    Ngwibete A; Ogunbode O; Swende LT; Agbada MM; Omigbodun A
    Pan Afr Med J; 2024; 47():50. PubMed ID: 38681110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are treatments for cervical precancerous lesions in less-developed countries safe enough to promote scaling-up of cervical screening programs? A systematic review.
    Chamot E; Kristensen S; Stringer JS; Mwanahamuntu MH
    BMC Womens Health; 2010 Apr; 10():11. PubMed ID: 20359354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of 'see-see and treat' strategy and role of HIV on cervical cancer prevention in Uganda.
    Mutyaba T; Mirembe F; Sandin S; Weiderpass E
    Reprod Health; 2010 May; 7():4. PubMed ID: 20459733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia.
    Korn AK; Muzingwani L; O'Bryan G; Ensminger A; Boylan AD; Kafidi EL; Kashali M; Ashipala L; Nitschke AM; Dziuban EJ; Forster N; Eckert LO; O'Malley G
    PLoS One; 2022; 17(2):e0263920. PubMed ID: 35171941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recurrences of precancerous lesions after conservative treatment: Operational results after a decade in Abidjan].
    Aka KE; Horo A; Koffi A; Fanny M; Diassana M; Kone M
    Gynecol Obstet Fertil Senol; 2021 Feb; 49(2):107-111. PubMed ID: 32763424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus-based cervical precancer screening with visual inspection with acetic acid triage to achieve same-day treatments among women living with human immunodeficiency virus infection: test-of-concept study in Ibadan, Nigeria.
    Awolude OA; Oyerinde SO; Ayeni AO; Adewole IF
    Pan Afr Med J; 2021; 40():48. PubMed ID: 34795828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervical cancer in the Hauts-Bassins region of Burkina Faso: Results of a screening campaign by visual inspection with acetic acid (VIA screening in Burkina Faso).
    Kagoné TS; Paré PG; Dembélé A; Kania D; Zida S; Bonané/Thiéba B; Ouédraogo A; Testa J; Simporé J; Méda N
    Afr J Reprod Health; 2022 Jun; 26(6):97-103. PubMed ID: 37585062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.